PharmaShots | Incisive News in 3 Shots

Subscribe Now

Immunome

Immunome to Acquire Ayala Pharmaceuticals’ AL102 for the Treatment of Desmoid Tumors

Immunome to Acquire Ayala Pharmaceuticals’ AL102 for the Treatment of Desmoid Tumors

February 7, 2024

Matthew Robinson, CTO, Immunome Shares Insights on Strategic Collaboration with AbbVie to Identify Multiple Novel Oncology Targets

Matthew Robinson, CTO, Immunome Shares Insights on Strategic Collaboration with AbbVie to Identify Multiple Novel Oncology Targets

May 9, 2023

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Canc...

August 2, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us